A federal appeals panel has temporarily blocked rules that allowed doctors to prescribe and mail abortion medication, dealing a significant setback to reproductive rights access and a notable victory for abortion restrictions advocates.
The 5th Circuit Court of Appeals sided with Louisiana on Friday in a challenge to Biden-era regulations that expanded access to mifepristone, the abortion drug now used in more than 60 percent of U.S. abortions. The state's legal argument centered on claims that federal rules contradicted its own protections for unborn life and forced Medicaid spending on emergency care related to the medication.
The three-judge panel's decision freezes a key pathway for obtaining the drug, which had become increasingly available through mail delivery without in-person clinic visits. A lower court judge had ruled just days earlier that mail prescriptions should continue during an ongoing Food and Drug Administration safety review, but the appeals court moved to halt that arrangement.
Reproductive rights groups quickly condemned the ruling as a barrier to essential healthcare. Regina Davis Moss, CEO of In Our Own Voice, an advocacy organization, framed the decision in terms of cost and burden. "At a time when families are struggling to afford basic needs like housing, groceries and child care, it is unconscionable to restrict lifesaving access to abortion medication," she said. "Reinstating in-person dispensing requirements would force people to travel farther, take more time off work, and absorb costs that are simply too high."
The ruling marks a turning point after the Supreme Court declined to revisit mifepristone access in 2024, dismissing a challenge brought by doctors who claimed they lacked legal standing to pursue the case. This latest decision from the 5th Circuit suggests the issue remains far from settled.
An emergency appeal to the Supreme Court is expected in the coming weeks, according to reproductive rights researchers tracking the litigation. The case underscores how abortion access remains a battleground between federal regulators and states seeking to restrict the practice.
Author James Rodriguez: "This ruling hands a major organizing victory to the anti-abortion movement at a moment when political momentum appears to be shifting in their favor."
Comments